Literature DB >> 7536778

Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.

H Kim1, H S Lee, K T Chang, T H Ko, K J Baek, N S Kwon.   

Abstract

N-alpha-tosyl-L-phenylalanine chloromethyl ketone (TPCK) and N-alpha-tosyl-L-lysine chloromethyl ketone (TLCK), serine protease inhibitors, block many cytotoxic functions of immune cells including superoxide anion production, cytokine release, cell-mediated cytolysis, and nitric oxide (NO)-related macrophage functions. IFN-gamma/LPS-induced NO production from murine peritoneal macrophages was inhibited by TPCK and TLCK in a dose-dependent manner (EC50s: approximately 20 microM for TPCK and approximately 30 microM for TLCK). Viability exceeded 91% with 25 microM TPCK and with 80 microM TLCK. When TPCK treatment was delayed until 1 h of activation, the inhibitory effect was markedly reduced. After 2 h of the activation, TPCK was not effective anymore. Addition of either TNF-alpha or conditioned media from IFN-gamma/LPS-activated macrophage culture did not prevent the inhibitory effect of TPCK. Neither TPCK nor TLCK reduced enzymatic NO production from macrophage lysates. Lysates from TPCK-treated cells did not generate NO even after supplementing necessary cofactors for NO synthase. Immunoblotting analysis showed that simultaneous treatment of TPCK with IFN-gamma/LPS abolished the NO synthase expression, whereas delayed addition of TPCK was either partially effective or not effective at all. Furthermore, TPCK treatment reduced the concentration of mRNA for NO synthase without decreasing mRNA stability. Thus, the serine protease inhibitors directly blocked an early event in expression of NO synthase. Electrophoretic mobility shift assay indicated that TPCK blocked the activation of nuclear factor-kappa B, a transcription factor necessary for NO synthase induction. TPCK also blocked disappearance of I kappa B from cytosolic fraction, and nuclear translocation of NF-kappa B subunits p50 and p65. Delaying the addition of TPCK by 10 min partially prevented the inhibition of the NF-kappa B activation process and allowed partial resuming of NO production. Thus, TPCK inhibited NO synthase induction by blocking NF-kappa B activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536778

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Activation of nuclear factor kappa B inflammatory bowel disease.

Authors:  S Schreiber; S Nikolaus; J Hampe
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

2.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

3.  Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.

Authors:  J M Griscavage; S Wilk; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol.

Authors:  S H Tsai; S Y Lin-Shiau; J K Lin
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages.

Authors:  S Klasen; R Hammermann; M Fuhrmann; D Lindemann; K F Beck; J Pfeilschifter; K Racké
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

6.  Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells.

Authors:  M S Islam; K Horiguchi; S Iino; N Kaji; S Mikawa; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2016-07-19       Impact factor: 8.739

7.  Protective role of α-lipoic acid in hyperuricemia-induced endothelial dysfunction.

Authors:  Hui Zou; Huan Wang; Tongmei Liu; Xiaojie Li; Xiaoduo Zhu; Zheng Wang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

8.  Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.

Authors:  Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

9.  Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Guido Mele; Barbara Iovine; Maria Assunta Bevilacqua; Luigi Greco; Salvatore Auricchio; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-04       Impact factor: 3.000

10.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.